The second stage included “glucagon like peptide 1,” “lipid metabolism,” “staphylococcus aureus,” “c reactive protein,” etc., elucidating the possible influence of inflammatory indicators and various disorders of glycolipid metabolism on the pathogenesis of heart failure, and paving the way for the study of specific mechanisms of gut microbiota in heart failure. The gene discussed is GCG; the disease is heart failure.